Dalton Medicinal Chemistry Partners and Boehringer Ingelheim (Canada) Ltd. enter into a Medicinal Chemistry Agreement
Dalton medicinal chemistry Partners, the Medicinal Chemistry arm of Dalton Pharma Services, announced the signing of a Medicinal Chemistry agreement with Boehringer Ingelheim (Canada) Ltd.
Dalton Medicinal Chemistry Partners will utilize their medicinal chemistry expertise to design and synthesize novel compounds against a number of antiviral targets selected by Boehringer Ingelheim (Canada) Ltd.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.